|
|
|
| Analysis of the maternal-infant outcomes and the risk factors of advanced pregnant women with gestational diabetes mellitus |
| Jianyang People's Hospital, Jianyang, Sichuan Province, 641400 |
|
|
|
|
Abstract To analyze the maternal-infant outcomes and the risk factors of advanced pregnant women with gestational diabetes mellitus (GDM). Methods: A total of 183 advanced pregnant women with GDM admitted to hospital from June 2019 to June 2023 were selected in study group. Meanwhile, 150 healthy advanced pregnant women were selected in the control group. The maternalinfant outcomes of the women were compared between the two groups. Multivariate logistic regression analysis was conducted to analyze the risk factors of GDM occurrence of the women. Results: The incidences of the cesarean section (53.0%), the polyhydramnios (10.4%), the preeclampsia (18.6%), the postpartum hemorrhage (9.3%) and the gestational hypertension (13.1%) of the women in the study group were significantly higher than those (38.7%, 3.3%, 6.7%, 1.3% and 2.7%) of the women in the control group. The rates of the premature birth (9.3%), the macrosomia (9.8%), the neonatal asphyxia (10.4%) and the fetal distress (19.1%) in the study group were also significantly higher than those (2.0%, 3.3%, 4.0% and 7.3%) in the control group (all P＜0.05). Multivariate analysis showed that the pre-pregnancy body mass index (BMI) ≥24kg/m2, the daily exercise time <2h/day and the family history of diabetes of the advanced pregnant women were the independent risk factors of their GDM occurrence, and the high education level of the advanced pregnant women was a protective factor of their GDM occurrence (all P＜0.05). Conclusion: The advanced pregnant women with GDM will increase the risk of their adverse maternal-infant outcomes, and their GDM occurrence is closely related to the higher pre-pregnancy BMI, the less daily exercise and the family history of diabetes of the women, so which should be paid attention to and the corresponding intervention measures should be taken to the women for improving their maternal and infant outcomes in clinic.
|
|
|
|
|
|
|
|
|
